The SULT2A1 gene significantly affects the metabolism of drugs like budesonide through sulfation processes that influence drug solubility and elimination. Variants in the SULT2A1 gene may alter enzymatic activity, impacting budesonide's bioavailability and efficacy, which is critical for personalized medicine strategies in treating inflammatory conditions and hormone-sensitive cancers.